Sign in

CIK 0001728117 · Non-accelerated filer<br>Smaller reporting company

Gossamer Bio, Inc.

Sign in to watch
Ticker
GOSS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
475461709
Phone
(858) 684-1300
Business address
3115 MERRYFIELD ROW, SUITE 120, SAN DIEGO, CA, 92121
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 6 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-02-14 Salter-Cid Luisa Chief Scientific Officer Grant or award · Stock Option (right to buy) +71,500 71,500
2020-02-14 Christian Waage EVP & General Counsel Grant or award +46,500 547,998
2020-02-14 Christian Waage EVP & General Counsel Grant or award · Stock Option (right to buy) +71,500 71,500
2020-02-14 Giraudo Bryan Chief Financial Officer Grant or award +46,500 70,379
2020-02-14 Giraudo Bryan Chief Financial Officer Grant or award · Stock Option (right to buy) +71,500 71,500
2020-02-14 Gujrathi Sheila President & CEO Grant or award +189,500 189,500
2020-02-14 Gujrathi Sheila President & CEO Grant or award · Stock Option (right to buy) +292,000 292,000
2019-12-31 Salter-Cid Luisa Chief Scientific Officer Gift −4,000 120,056
2019-12-30 Dupont Jakob Chief Medical Officer Option exercise +40,000 $10.71 $428K 40,000
2019-12-30 Dupont Jakob Chief Medical Officer Sale −40,000 $15.00 $600K 0
2019-12-30 Dupont Jakob Chief Medical Officer Option exercise · Non-qualified stock option (Right to Buy) −40,000 439,317
2019-12-27 Dupont Jakob Chief Medical Officer Option exercise +1,994 $10.71 $21K 1,994
2019-12-27 Dupont Jakob Chief Medical Officer Sale −1,994 $15.81 $32K 0
2019-12-27 Dupont Jakob Chief Medical Officer Option exercise · Non-qualified stock option (Right to Buy) −1,994 479,317
2019-09-27 Christian Waage EVP & General Counsel Purchase +1,000 $16.65 $17K 4,454
2019-09-27 Hasnain Faheem Director Purchase +10,000 $16.80 $168K 3,382,109
2019-09-27 Gujrathi Sheila President & CEO Purchase +10,000 $16.80 $168K 4,048,242
2019-09-26 Giraudo Bryan Chief Financial Officer Purchase +1,121 $16.78 $19K 2,121
2019-09-20 Omega Fund V, L.P. 10% owner Sale −183,607 $21.96 $4.0M 6,553,416
2019-09-18 Omega Fund V, L.P. 10% owner Sale −45,600 $21.88 $998K 6,737,023

Page 18 of 21 · 401 trades